Tag: Novartis
-
AbbVie comms queen rises
- 05 May 2021
Kate Richards says while change is ‘everpresent’ in public affairs, this is much more evident in the new Covid world while Peta James and Kate Scott-Murphy take up new roles at GSK and Novartis.
Read more -
Aust in new Zolgensma trial
- 28 Apr 2021
One of four sites named globally where Novartis will trial its gene therapy in children as old as eight with spinal muscular atrophy.
Read more -
Novartis’ 50/50 gene payment plan
- 14 Apr 2021
New gene therapy Luxturna for ultra-rare vision loss offered on a pay-for-performance deal, with half the cost paid upfront.
Read more -
Novartis fined $200k for eye promotion
- 31 Mar 2021
Novartis’ attempt to move in on Bayer’s Eylea resulted in it being the last company fined under the outgoing MA Code.
Read more